Your browser doesn't support javascript.
loading
High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia.
Cui, Bing; Ghia, Emanuela M; Chen, Liguang; Rassenti, Laura Z; DeBoever, Christopher; Widhopf, George F; Yu, Jian; Neuberg, Donna S; Wierda, William G; Rai, Kanti R; Kay, Neil E; Brown, Jennifer R; Jones, Jeffrey A; Gribben, John G; Frazer, Kelly A; Kipps, Thomas J.
Afiliação
  • Cui B; Department of Medicine, Moores Cancer Center, University of California, San Diego, San Diego, CA.
  • Ghia EM; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Chen L; Department of Medicine, Moores Cancer Center, University of California, San Diego, San Diego, CA.
  • Rassenti LZ; Department of Medicine, Moores Cancer Center, University of California, San Diego, San Diego, CA.
  • DeBoever C; Department of Medicine, Moores Cancer Center, University of California, San Diego, San Diego, CA.
  • Widhopf GF; Bioinformatics and Systems Biology, University of California, San Diego, San Diego, CA.
  • Yu J; Department of Medicine, Moores Cancer Center, University of California, San Diego, San Diego, CA.
  • Neuberg DS; Department of Medicine, Moores Cancer Center, University of California, San Diego, San Diego, CA.
  • Wierda WG; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard University, Boston, MA.
  • Rai KR; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Kay NE; Department of Medicine, Hofstra North Shore-Long Island Jewish School of Medicine, Hempstead, NY.
  • Brown JR; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN.
  • Jones JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University, Boston, MA.
  • Gribben JG; Division of Hematology and Comprehensive Cancer Center, The Ohio State University, Columbus, OH.
  • Frazer KA; Department of Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK; and.
  • Kipps TJ; Moores Cancer Center, Department of Pediatrics and Rady Children's Hospital, Institute for Genomic Medicine, Chronic Lymphocytic Leukemia Research Consortium, University of California, San Diego, San Diego, CA.
Blood ; 128(25): 2931-2940, 2016 12 22.
Article em En | MEDLINE | ID: mdl-27815263
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Progressão da Doença / Receptores Órfãos Semelhantes a Receptor Tirosina Quinase Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Progressão da Doença / Receptores Órfãos Semelhantes a Receptor Tirosina Quinase Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article